143 filings
Page 6 of 8
8-K
2o2q 94cvbynf
3 Dec 18
Departure of Directors or Certain Officers
8:06am
8-K
7zga df9nk3ih37s8x
8 Nov 18
Selecta Biosciences Announces Third Quarter 2018
8:05am
8-K
uwvz8teu 9dc8lp59
23 Oct 18
Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018
7:10am
8-K
wf2gkkdju 0k
22 Oct 18
Regulation FD Disclosure
8:01am
8-K
tyispzf3f0p9wm0q
17 Oct 18
Other Events
4:49pm
8-K
pid9et
27 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
ru0ph14amk7fr
27 Sep 18
Regulation FD Disclosure
12:00am
8-K
efc y25qmajxrgzzb
9 Aug 18
Regulation FD Disclosure
7:46am
8-K
9otf7bjw39i52vgp0
8 Aug 18
Selecta Biosciences Announces Second Quarter 2018
8:04am
8-K
t1navf4fj89b mrbvc
19 Jun 18
Submission of Matters to a Vote of Security Holders
7:32am
8-K
ajfihx7fnzvue
15 Jun 18
Selecta Biosciences Presents Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018
12:00am
8-K
k5q pkclvzr55
4 Jun 18
Regulation FD Disclosure
12:00am
8-K
aaauarw0o ljnv
9 May 18
Selecta Biosciences Announces First Quarter 2018
8:06am
8-K
skm0iau7
10 Apr 18
Selecta Biosciences Presents Positive New Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at PANLAR 2018 Congress
12:00am
8-K
sttd56ve2sjr
27 Mar 18
Regulation FD Disclosure
12:00am
8-K
8aedv4 hminye
15 Mar 18
Selecta Biosciences Announces Fourth Quarter and Year End 2017
12:00am
8-K
0j9p0w5
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
hifo5ngvz6ia
2 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
adpq7 ptrg88c3cyfwa
19 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
axdl0x6jv1cym
14 Nov 17
Regulation FD Disclosure
12:00am